-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Neutral on Zimmer Biomet Holdings, Lowers Price Target to $95

Benzinga·04/29/2026 20:37:11
Listen to the news
JP Morgan analyst Robbie Marcus maintains Zimmer Biomet Holdings (NYSE:ZBH) with a Neutral and lowers the price target from $100 to $95.